Business Wire (Tue, 15-Sep 8:00 AM ET)
TipRanks (Mon, 14-Sep 10:45 AM ET)
TipRanks (Mon, 14-Sep 6:25 AM ET)
GE HealthCare is said to near $1B Sofie Biosciences deal
Seeking Alpha News (Sun, 13-Sep 8:52 AM ET)
Business Wire (Tue, 8-Sep 8:00 AM ET)
GE HealthCare's Photonova Spectra gains CE Mark, expanding international access
Business Wire (Mon, 31-Aug 8:00 AM ET)
Business Wire (Fri, 28-Aug 6:45 AM ET)
GE HealthCare management to present at upcoming investor conference
Business Wire (Wed, 26-Aug 8:00 AM ET)
Globe Newswire (Thu, 20-Aug 11:00 AM ET)
Globe Newswire (Thu, 20-Aug 9:00 AM ET)
GE HealthCare Technologies is a leading medical technology firm with leading market share in imaging and ultrasound equipment. The company reports four major segments: imaging (45% of revenue), advanced visualization solutions (26%), patient care solutions (15%), and pharmaceutical diagnostics (14%). The company's sales are geographically diverse, with the United States, EMEA, China, and the rest of the world accounting for 46%, 26%, 11%, and 17%, respectively. We estimate approximately half of its revenue is recurring, which consists of servicing (about one-third of revenue), pharmaceutical diagnostics (about 10%-15%), and digital solutions (just over 5%).
Ge Healthcare Techs trades on the NASDAQ stock market under the symbol GEHC.
As of September 16, 2026, GEHC stock price declined to $63.72 with 590,660 million shares trading.
GEHC has a beta of 0.98, meaning it tends to be less sensitive to market movements. GEHC has a correlation of 0.11 to the broad based SPY ETF.
GEHC has a market cap of $28.78 billion. This is considered a Large Cap stock.
Last quarter Ge Healthcare Techs reported $5 billion in Revenue and $1.13 earnings per share. This beat revenue expectation by $32 million and exceeded earnings estimates by $.09.
In the last 3 years, GEHC traded as high as $94.80 and as low as $57.65.
The top ETF exchange traded funds that GEHC belongs to (by Net Assets): VTI, VOO, VO, QQQ, SPY.
GEHC has underperformed the market in the last year with a price return of -17.9% while the SPY ETF gained +16.2%. GEHC has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -1.6% and -9.5%, respectively, while the SPY returned +1.0% and -0.2%, respectively.
GEHC support price is $63.11 and resistance is $65.03 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that GEHC shares will trade within this expected range on the day.